# APLR (Amplara Corporation) - SEC EDGAR Financial Statements

> Amplara Corporation reported $32K in revenue and a net loss of $70K for the fiscal year ended August 31, 2026, with a -220.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/APLR
- Markdown: https://convexityos.com/fundamentals/APLR.md
- SEC CIK: 0002093096
- Reporting currency: USD
- Latest filing period: August 31, 2026
- Last synced: Nov 21, 2026, 05:18 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002093096&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | $32K | Aug 31, 2026 |
| Operating Income | FY 2026 | -$70K | -220.0% margin |
| Net Income | FY 2026 | -$70K | -220.0% net margin |
| Diluted EPS | FY 2026 | -- | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Aug 31, 2026 | $5.2K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 |
| --- | --- | --- |
| **Revenue** | $32K | -- |
| Total Operating Expenses | $102K | $9.4K |
| **Operating Income** | -$70K | -$9.4K |
| Income Before Tax | -$70K | -- |
| **Net Income** | -$70K | -$9.4K |
| Basic EPS | -$0.03 | -$0.01 |
| Basic Shares Outstanding | 2.8M | 1.5M |

### Income Statement (Quarterly)

| Line Item | May 2026 | Feb 2026 | May 2025 |
| --- | --- | --- | --- |
| **Revenue** | $6.5K | $1.1K | -- |
| Total Operating Expenses | $27K | $23K | $214 |
| **Operating Income** | -$21K | -$22K | -$214 |
| **Net Income** | -$21K | -$22K | -$214 |
| Basic EPS | -$0.01 | -$0.01 | -- |
| Basic Shares Outstanding | 3.2M | 2.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 |
| --- | --- | --- |
| Cash & Cash Equivalents | $5.2K | $190 |
| **Cash & Short-Term Investments** | $5.2K | $190 |
| **Total Current Assets** | $29K | $190 |
| Intangible Assets | $95K | $19K |
| **Total Non-Current Assets** | $95K | $19K |
| **Total Assets** | $124K | $20K |
| **Total Current Liabilities** | $149K | $19K |
| **Total Non-Current Liabilities** | $0 | $0 |
| **Total Liabilities** | $149K | $19K |
| Common Stock | $3.8K | $2.0K |
| Retained Earnings | -$80K | -$9.4K |
| **Total Stockholders' Equity** | -$24K | $600 |
| Total Equity | -$24K | $600 |

### Balance Sheet (Quarterly)

| Line Item | Aug 2026 | May 2026 | Feb 2026 | Aug 2025 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.2K | $442 | $2.6K | $190 |
| **Cash & Short-Term Investments** | $5.2K | $442 | $2.6K | $190 |
| **Total Current Assets** | $29K | $23K | $2.6K | $190 |
| Intangible Assets | $95K | $55K | $47K | $19K |
| **Total Non-Current Assets** | $95K | $55K | $47K | $19K |
| **Total Assets** | $124K | $78K | $49K | $20K |
| **Total Current Liabilities** | $149K | $97K | $90K | $19K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $149K | $97K | $90K | $19K |
| Common Stock | $3.8K | $3.8K | $2.1K | $2.0K |
| Retained Earnings | -$80K | -$74K | -$53K | -$9.4K |
| **Total Stockholders' Equity** | -$24K | -$19K | -$41K | $600 |
| Total Equity | -$24K | -$19K | -$41K | $600 |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 |
| --- | --- | --- |
| Net Income | -$70K | -$9.4K |
| **Operating Cash Flow** | -$19K | -- |
| **Investing Cash Flow** | -$92K | -- |
| Common Stock Issued | $45K | -- |
| **Financing Cash Flow** | $116K | -- |
| **Net Change in Cash** | $5.0K | -- |

### Cash Flow Statement (Quarterly)

| Line Item | May 2026 | Feb 2026 | May 2025 |
| --- | --- | --- | --- |
| Net Income | -$21K | -$22K | -$214 |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 |
| --- | --- | --- |
| **Operating Margin** | -220.0% | -- |
| **Net Profit Margin** | -220.0% | -- |
| Return on Equity (ROE) | -- | -1566.7% |
| Return on Assets (ROA) | -56.5% | -48.1% |
| Current Ratio | 0.20x | 0.01x |
| Quick Ratio | 0.04x | 0.01x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | May 2026 | Feb 2026 | May 2025 |
| --- | --- | --- | --- |
| Current Ratio | 0.24x | 0.03x | -- |
| Quick Ratio | 0.00x | 0.03x | -- |

## Related Companies

[IBO (Impact BioMedical, INC.)](https://convexityos.com/fundamentals/IBO), [NVNO (enVVeno Medical Corporation)](https://convexityos.com/fundamentals/NVNO), [GLVT (Greenlit Ventures Inc.)](https://convexityos.com/fundamentals/GLVT), [CLOW (Cloudweb, Inc.)](https://convexityos.com/fundamentals/CLOW), [EDVA (Endovia Health Sciences, Inc.)](https://convexityos.com/fundamentals/EDVA), [NMEX (Northern Minerals & Exploration Ltd.)](https://convexityos.com/fundamentals/NMEX), [SINC (Sincerity Applied Materials Holdings Corp.)](https://convexityos.com/fundamentals/SINC), [MINR (Minerva Gold Inc.)](https://convexityos.com/fundamentals/MINR)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
